Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2024). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA256893
National Cancer Institute
Grant: R01 CA272483
NCI NIH HHS
Grant: R01 CA157429
NCI NIH HHS
Grant: P30 CA177558
NCI NIH HHS
Grant: R01 CA264652
Markey Cancer Center, University of Kentucky
FWCI
1.44
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals